Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
March 10, 2005
Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability
D Holstead Jones, Tony Y Li, Elena Arystarkhova, et al.
Circulation
|
April 11, 2001
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction
M Jain, H DerSimonian, D A Brenner, et al.
Journal of Internal Medicine
|
July 3, 2009
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure
M Potocki, T Breidthardt, T Reichlin, et al.
Genes & Development
|
March 3, 2010
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway
Margareta T Wilhelm, Alessandro Rufini, Monica K Wetzel, et al.
The Journal of Biological Chemistry
|
November 30, 2002
The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice
Amy E Moseley, Steve P Lieske, Randall K Wetzel, et al.
Clinical Pharmacology and Therapeutics
|
August 4, 2021
Safety, Tolerability, and Pharmacokinetics of High-Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers
Michael J Dolton, Aaron Chesterman, Anita Moein, et al.
Neuron
|
September 13, 2008
p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer's disease
Monica K Wetzel, Sibel Naska, Christine L Laliberté, et al.
Nature Communications
|
May 3, 2025
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier
Julien Lafrance-Vanasse, Shraddha S Sadekar, Yanli Yang, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Cancer Cell
|
June 12, 2019
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
March 10, 2005
Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered Na+ affinity and decreased thermal stability
D Holstead Jones, Tony Y Li, Elena Arystarkhova, et al.
Circulation
|
April 11, 2001
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction
M Jain, H DerSimonian, D A Brenner, et al.
Journal of Internal Medicine
|
July 3, 2009
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure
M Potocki, T Breidthardt, T Reichlin, et al.
Genes & Development
|
March 3, 2010
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway
Margareta T Wilhelm, Alessandro Rufini, Monica K Wetzel, et al.
The Journal of Biological Chemistry
|
November 30, 2002
The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice
Amy E Moseley, Steve P Lieske, Randall K Wetzel, et al.
Clinical Pharmacology and Therapeutics
|
August 4, 2021
Safety, Tolerability, and Pharmacokinetics of High-Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers
Michael J Dolton, Aaron Chesterman, Anita Moein, et al.
Neuron
|
September 13, 2008
p73 regulates neurodegeneration and phospho-tau accumulation during aging and Alzheimer's disease
Monica K Wetzel, Sibel Naska, Christine L Laliberté, et al.
Nature Communications
|
May 3, 2025
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier
Julien Lafrance-Vanasse, Shraddha S Sadekar, Yanli Yang, et al.
Cancer Cell
|
January 15, 2016
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Cancer Cell
|
June 12, 2019
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, et al.
Page
of 8